Evidence map›Paper›PMID 34111207›Full record

ArticlePloS one2021

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review.

Emily Duncanson, Richard K Le Leu, Lisa Shanahan, Luke Macauley, Paul N Bennett, Rick Weichula, Stephen McDonald, Anne L J Burke, Kathryn L Collins, Anna Chur-Hansen and 1 more

2 registry-linked trialsOpen access · goldAbstract readScoping Review
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06996379 narecruitingnot on this mapstarted 2025, after this paper: background citation

Use of the J-Tip Needle-Free Injection System With 1% Lidocaine to Reduce Paracentesis-Related Discomfort

TypeinterventionalSponsorNorthwestern UniversityRan2025 to 2027Enrolled110ConditionsEvaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the SkinArmsExperimental J-Tip Needle-Free Injection System, Control (Standard treatment)
NCT07300618 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effect of Stress Ball And Music on Anxiety, Stress, and Pain Levels During Platelet Apheresis Donation: Randomized Controlled Trial

TypeinterventionalSponsorSaglik Bilimleri UniversitesiRan2024 to 2025Enrolled102ConditionsAnxiety, StressArmsmüzik resital, stres topu, aferez makinesi, antikoagülan çözelti
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Trial
  5. Trial
  6. Trial
  7. Review
  8. The promise of oral IL-23 blockade: One-year control of high-impact site psoriasis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Emily DuncansonCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Richard K Le LeuCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID 0000-0003-4704-4943
Lisa ShanahanParamount Health Service, Adelaide, South Australia, Australia.
Luke MacauleyPatient Partner for Central and Northern Adelaide Renal and Transplantation Service Clinical Research Group, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Paul N BennettClinical and Health Services, University of South Australia, Adelaide, Australia.ORCID 0000-0001-9174-3499
Rick WeichulaCentre for Evidence-based Practices, South Australia, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia.
Stephen McDonaldCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Anne L J BurkeSchool of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia.ORCID 0000-0002-0109-2950
Kathryn L CollinsSchool of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia.ORCID 0000-0003-3371-9452
Anna Chur-HansenSchool of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia.
Shilpanjali JesudasonCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Royal Adelaide Hospital · AUThe University of Adelaide · AUSA Health · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about the prevalence and best management of needle fear in adults with chronic disease, who may experience frequent and long-term exposure to needles for lifesaving therapies such as renal dialysis and cancer treatment. Identifying interventions that assist in management of needle fear and associated distress is essential to support these patients with repeated needle and cannula exposure.

methodWe followed the PRISMA methodology for scoping reviews and systematically searched PsychINFO, PubMed (MEDLINE), ProQuest, Embase and grey literature and reference lists between 1989 and October 2020 for articles related to needle discomfort, distress, anxiety, fear or phobia. The following chronic diseases were included: arthritis, asthma, chronic back pain, cancer, cardiovascular disease, chronic obstructive pulmonary disease, diabetes, and mental illness, or kidney failure. Literature concerning dentistry, vaccination, intravenous drug users and paediatric populations were excluded.

resultsWe identified 32 papers reporting prevalence (n = 24), management (n = 5) or both (n = 3). Needle fear prevalence varied in disease cohorts: 17-52% (cancer), 25-47% (chronic kidney disease) and 0.2-80% (diabetes). Assessment methods varied across studies. Management strategies had poor evidence-base, but included needle-specific education, decorated devices, cognitive-behavioural stress management techniques, distraction, and changing the therapy environment or modality.

conclusionAlthough needle fear is common there is a paucity of evidence regarding interventions to address it among adults living with chronic disease. This scoping review has highlighted the need for improved identification of needle fear in adults and development of interventions are required for these cohorts.

Indexed as

AdultChronic DiseaseCognitive Behavioral TherapyDisease ManagementEvidence-Based MedicineHumansPhobic DisordersPrevalence

Identifiers

PMID34111207
PMCPMC8192004
OpenAlexW3168018452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.